PTPRC and B-cell non-Hodgkin lymphoma: Further characterization with human-CD3/CD20 co-staining showed that CD45+ tumors were composed predominantly of CD20+ cells with a minority of cells expressing CD3, consistent with B-cell lymphomas (Fig. 2A).